$28.560
+3.490 (+12.22%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
VYNE Prediction & Forecast by Similar Chart Analysis
Alphio's VYNE stock price prediction model matches the current Vyne Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $28.60 (+0.13%). The 1-week path is $28.75 (+0.66%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Vyne Therapeutics Inc Stock?
Based on the provided data, Vyne Therapeutics Inc (VYNE) does not present a compelling buy opportunity for a beginner investor with a long-term strategy. The technical indicators are neutral to slightly bearish, there are no positive trading signals, no recent news or catalysts, and no financial data to assess growth trends. The lack of significant positive momentum or catalysts suggests holding off on this stock for now.
VYNE stock price ended at $28.56 on Monday, after rising +12.22%
Vyne Therapeutics Inc (VYNE) last closed at $28.56, gaining +12.22%. These facts feed the 1-day and 1-week VYNE price prediction above.
Forecast Drivers
Vyne Therapeutics Inc (VYNE) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bearish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches VYNE, ranked by similarity.
Seasonality analysis for VYNE
Historically the probability of a positive August return for VYNE is 0.00%. May offers the highest probability of a positive month at 66.67%, while August is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for VYNE
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $1.37 | $1.42 | $1.67 | -95.04% |
| Sep 2026 | $1.19 | $1.22 | $1.30 | -95.71% |
| Oct 2026 | $1.30 | $1.34 | $1.62 | -95.31% |
| Nov 2026 | $1.02 | $1.14 | $1.40 | -95.99% |
| Dec 2026 | $1.13 | $1.14 | $1.15 | -95.99% |
In 2026, Vyne Therapeutics Inc (VYNE) is projected to range from $1.02 to $1.67.
Vyne Therapeutics Inc 2026 monthly forecast
In Aug 2026, Vyne Therapeutics Inc is projected to average $1.42, with a low of $1.37 and high of $1.67.
In Sep 2026, Vyne Therapeutics Inc is projected to average $1.22, with a low of $1.19 and high of $1.30.
In Oct 2026, Vyne Therapeutics Inc is projected to average $1.34, with a low of $1.30 and high of $1.62.
In Nov 2026, Vyne Therapeutics Inc is projected to average $1.14, with a low of $1.02 and high of $1.40.
In Dec 2026, Vyne Therapeutics Inc is projected to average $1.14, with a low of $1.13 and high of $1.15.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.